# EDGAR Filing Document

**Accession Number:** 0001187953
**File Stem:** 0001477932-26-004097
**Filing Date:** 2026-6
**Character Count:** 2805
**Document Hash:** 434d40f5c566b0084b29a9f8d582ca7e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-26-004097.hdr.sgml**: 20260630

**ACCESSION NUMBER**: 0001477932-26-004097

**CONFORMED SUBMISSION TYPE**: RW

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260630

**DATE AS OF CHANGE**: 20260630

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
- **CENTRAL INDEX KEY:** 0001187953
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 870622284
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** RW

**SEC ACT:**
- **SEC FILE NUMBER:** 333-297026
- **FILM NUMBER:** 261138113

**BUSINESS ADDRESS:**
- **STREET 1:** 211 E. OSBORN RD.
- **CITY:** PHOENIX
- **STATE:** AZ
- **ZIP:** 85012
- **BUSINESS PHONE:** 480-399-2822

**MAIL ADDRESS:**
- **STREET 1:** 211 E. OSBORN RD.
- **CITY:** PHOENIX
- **STATE:** AZ
- **ZIP:** 85012

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JOLLEY MARKETING INC
- **DATE OF NAME CHANGE:** 20020910

![](celz_rwimg1.jpg)

June 30, 2026

<u>Via Edgar</u>

Ms. Jessica Dickerson

Division of Corporation Finance

Office of Life Sciences

U.S. Securities and Exchange Commission

Washington, D.C. 20549

---

| | |
|:---|:---|
| Re: | Creative Medical Technology Holdings, Inc. |
|  | Request for Withdrawal of Registration Statement on Form S-1 |
|  | Filed June 25, 2026 |
|  | File No. 333-297026 |

---

Dear Ms. Dickerson:

Pursuant to Rule 477 under the Securities Act of 1933, as amended (the "Securities Act"), Creative Medical Technology Holdings, Inc. (the "Company") hereby requests that the above-referenced Registration Statement be withdrawn, effective as of the date hereof. The Company is withdrawing the Registration Statement because it no longer plans to consummate the offering of its securities described in the Registration Statement. The Registration Statement has not been declared effective by the Securities and Exchange Commission (the "SEC"), and no securities have been issued or sold thereunder. Accordingly, the Company believes that the withdrawal of the Registration Statement is consistent with the public interest and the protection of investors.

The Company requests that, in accordance with Rule 457(p) of the Securities Act and subject to compliance with the requirements thereof, all fees paid to the SEC in connection with the filing of the Registration Statement be credited for future use.

Please contact Zev M. Bomrind of Pachulski Stang Ziehl & Jones LLP, counsel to the Company, at (646) 483-5497, if you have any other questions or concerns regarding this matter.

---

| |
|:---|
| Sincerely, |
| */s/ Timothy Warbington* |
| Timothy Warbington |
| Chief Executive Officer |

---